Gastroezofageal'naya reflyuksnaya bolezn' i “kislotnyy karman”


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the current data on the pathogenesis of gastroesophageal reflux disease (GERD). The role of the “acid pocket" as a source of gastroesophageal reflux is demonstrated. The approaches to the treatment of the disease from the perspective of impact on the “acid pocket" are discussed. Antireflux mechanism of action of alginates, and their importance in the diagnosis and treatment of GERD are disclosed.

Full Text

Restricted Access

About the authors

D. S Bordin

S. V Kolbasnikov

References

  1. Vakil N, van Zanden SV, Kahrilas P, et al. The Monreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. Am J Gastroenterol 2006;101:1900-20.
  2. Tytgat G. Патогенез ГЭРБ//Эксперим. и клин. гастроэнтерол. 2004. № 5 (Спецвыпуск). С. 6-11.
  3. Pandolfino JE, Zhang QG, Ghosh SK, et al. Transient lower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry. Gastroenterology 2006;131:1725-33.
  4. Iijima K, Henry E, Moriya A, et al. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology 2002;122(5):1248-57.
  5. Pandolfino JE, Ghosh SK, Zhang Q, et al. Upper sphincter function during transient lower oesophageal sphincter relaxation (tLOSR); it is mainly about microburps. Neurogastroenterol. Motil 2007;19:203-10.
  6. Sifrim D, Holloway R. Transient lower esophageal sphincter relaxations: how many or how harmful? Am J Gastroenterol 2001;96: 2529-32.
  7. Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology 2000;118(4):688-95.
  8. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307:1547-52.
  9. McLaughlan G, Fullarton GM, Crean GP, McColl KE. Comparison of gastric body and antral pH: a 24 hour ambulatory study in healthy voluteers. Gut 1989;30:573-78.
  10. Smith JL, Opekun AR, Larkai E, Graham DY. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989;96:683-89.
  11. Sudhir K, Dutta HBM, Meirowitz RF, Vaeth J. Modulation of salivary secretion by acid infusion in the distal oesophagus in-humans. Gastroenterology 1992;103:1833-41.
  12. Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001;121(4):775-83.
  13. Beaumont H, Bennink RJ, de Jong J, et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010;59:441-51.
  14. Sgouros SN, Mpakos D, Rodias M, et al. Prevalence and axial length of hiatus hernia in patients, with nonerosive reflux disease: a prospective study. J Clin Gastroenterol 2007;41:814-18.
  15. Scheffer RC, Bredenoord AJ, Hebbard GS, et al. Effect of proximal gastric volume on hiatal hernia. Neurogastroenterol Motil 2010;22:552-6.
  16. Rohof WO, Bennink RJ, de Ruigh AA, et al. Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. Gut 2012 Jan 20. [Epub ahead of print].
  17. Dubais A. What is the correlation between gastric secretory volume and reflux frequency? The Esophagogastric Junction. Ed. by Giuli R, Galmiche J-P, Jamieson G, Scarpignato C. Paris, 1998:416-19.
  18. Namiot Z, Sarosiek J, Rourk RM, McCallum RW. Human esophageal secretion: mucosal response to luminal acid and pepsin. Gastroenterology 1994;106:973-81.
  19. Zaninotto G, Costantini M, Di Mario F, et al. Esophagitis and pH of the refluxate: experimenal and clinical study. Br J Surg 1992;79:161-64.
  20. Van Pinxteren B, Numan ME, Bonis PA, et al. Shortterm treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004;(4):CD002095.
  21. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gas-tro-oesophageal reflux disease - where next? Aliment Pharmacol Ther 2005;22:79-94.
  22. AGA. GERD patient study: Patients and their medications. [Обращение к документу: 2008]. Доступ через http://www.gastro.org/user-assets/documents/13_Media/GERD_Survey_ Final_ Report_2.pdf.
  23. Лазебник Л.Б., Бордин Д.С., Машарова А.А. и др. Эффективность ланзоптола при гастроэзофагеальной рефлюксной болезни: результаты многоцентрового исследования "ЛИДЕР"// Эксперим. и клин. гастроэнтерол. 2010. № 7. С. 112-20.
  24. Dean BB, Gano A Jr, Knight K, et al. Эффективность ингибиторов протонной помпы при неэрозивной рефлюксной болезни // Клин. гастроэнтер. и гепатол. (Русское издание) 2008. № 3. С. 176-83.
  25. Rubenstein JH, Nojkov B, Korsnes S, et al. Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:443-52.
  26. Лазебник Л.Б., Бордин Д.С., Машарова А.А. и др. Факторы, влияющие на эффективность лечения ГЭРБ ингибиторами протонной помпы// Тер. архив 2012. № 2. С. 16-21.
  27. Исаков В.А. НЭРБ и ЭРБ: две стороны одной медали? // Клин. гастроэнтер. и гепатол. (Русское издание) 2008. № 3. С. 166-68.
  28. Лазебник Л.Б., Бордин Д.С., Машарова А.А. Длительная терапия ингибиторами протонной помпы: баланс пользы и рисков // Эксперим. и клин. гастроэнтер. 2010. № 9. С. 3-8.
  29. Strugala V, Avis J, Jolliffe IG, et al. The role of an alginate suspension on pepsin and bile acids -key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease? J Pharm Pharmacol 2009;61(8):1021-28.
  30. Бордин Д.С., Машарова А.А., Фирсова Л.Д. и др. Оценка скорости начала действия и купирования изжоги при однократном приеме альгинатов у больных ГЭРБ // Эксперим. и клин. гастроэнтерол. 2009. № 4. С. 83-91.
  31. Manabe N, Haruma K, Ito M, et al. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial. Dis Esophagus 2011; Nov 2 [Epub ahead of print].
  32. Dettmar PW, Hampson FC, Jain A, et al. Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res 2006;123(4):517-24.
  33. Fass R. Persistent heartburn in a patient on proton-pump inhibitor. Clin gastroenterol hepatol 2008;6:393-400.
  34. Tran T, Lowry AM, El-Serag HB. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther 2007;25(2):143-53.
  35. Kapadia CJ, Mane VB. Raft-forming agents: antireflux formulations. Drug Dev Ind Pharm 2007;33(12):1350-61.
  36. Лазебник Л.Б., Бордин Д.С., Машарова А.А. и др. "Восстановление качества жизни устранением и предотвращением изжоги альгинатом": результаты многоцентрового исследования "ВИА АПИА" // Эксперим. и клин. гастроэнтерол. 2010. № 6. С. 70-6.
  37. Mandel KG, Daggy BP, Brodie DA, Jacoby HI. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther 2000;14:669-90.
  38. Бордин Д.С., Машарова А.А., Дроздов В.Н., Фирсова Л.Д., Кожурина Т.С. Диагностиче ское значение альгинатного теста при гастроэзофагеальной рефлюксной болезни // Эксперим. и клин. гастроэнтерол. 2010. № 12. С. 102-7.
  39. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
  40. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection -the Maastricht IV. Florence Consensus Report. Gut 2012;61:646-64.
  41. Kwiatek MA, Roman S, Fareeduddin A, Pandolfino JE, Kahrilas PJ. An alginate antacid formulation (Gaviscon Double Action liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients. Aliment Pharmacol Ther 2011;31(1):59-66.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies